AI assistant
Sending…
CONMED Corp — Director's Dealing 2012
Jun 15, 2012
31971_dirs_2012-06-15_833f4ce4-287e-4576-bfb2-92976f2af0c3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-06-01
Reporting Person: CORASANTI EUGENE R (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-06-01 | Rsus (restricted Stock Units) | $0 | A | 5000 | Acquired | 2022-06-01 | Common Stock (5000) | Direct |
| 2012-06-01 | Sars (Stock Appreciation Rights) | $26.09 | A | 2500 | Acquired | 2022-06-01 | Common Stock (2500) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the SARs generally vesting 100% after a one year period.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7